Achieve Life Sciences
ACHV
65 hedge funds and large institutions have $70.9M invested in Achieve Life Sciences in 2014 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 21 increasing their positions, 14 reducing their positions, and 8 closing their positions.
50% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 8
50% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 14
23% more capital invested
Capital invested by funds: $57.7M → $70.9M (+$13.3M)
7% more funds holding
Funds holding: 61 → 65 (+4)
28% less call options, than puts
Call options by funds: $5.46M | Put options by funds: $7.59M
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
+$2.36M |
| 2 |
TC
TFS Capital
West Chester,
Pennsylvania
|
+$1.38M |
| 3 |
TA
Teachers Advisors
New York
|
+$1.25M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.25M |
| 5 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$958K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
Tang Capital Management
San Diego,
California
|
-$8.62M |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
-$3.93M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.77M |
| 4 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$928K |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$618K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
DCM
76
DAFNA Capital Management
Los Angeles,
California
| – | -$928K | -51 | Closed |
|
|
SFM
77
Sphera Funds Management
Tel Aviv,
Israel
| – | -$618K | -34 | Closed |
|
|
NI
78
Numeric Investors
Boston,
Massachusetts
| – | -$469K | -26 | Closed |
|
79
Two Sigma Investments
New York
| – | -$181K | -10 | Closed |
|
|
WAM
80
Wolverine Asset Management
Chicago,
Illinois
| – | -$79K | -4 | Closed |
|
ACHV Hedge Fund Activity: Q1 2014 in Review
65 of the 3,464 institutional investors tracked by Wall St. Rank reported a position in Achieve Life Sciences (ACHV) for Q1 2014, worth a combined $70.9M — up 23% from $57.7M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new ACHV positions and 8 closed out — a net gain of 4 holders — while 21 added to existing stakes and 14 trimmed.
The largest buyer was Bogle Investment Management, opening a new position worth an estimated $2.36M. The largest seller was Tang Capital Management, exiting entirely with an estimated $8.62M sold.
- 65 institutional investors held Achieve Life Sciences (ACHV) as of Q1 2014, up from 61 in Q4 2013.
- Funds reported $70.9M of Achieve Life Sciences stock for Q1 2014, up 23% quarter-over-quarter.
- 12 funds opened new Achieve Life Sciences positions in Q1 2014 and 8 closed out, a net change of +4 holders.
- The largest Achieve Life Sciences buyer in Q1 2014 was Bogle Investment Management, an estimated $2.36M added.
- The largest Achieve Life Sciences seller in Q1 2014 was Tang Capital Management, an estimated $8.62M sold.
Based on aggregated 13F filings for Q1 2014.